Greenwich LifeSciences Statistics
Total Valuation
GLSI has a market cap or net worth of $226.43 million. The enterprise value is $220.92 million.
| Market Cap | 226.43M |
| Enterprise Value | 220.92M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, after market close.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GLSI has 12.88 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Shares Outstanding | 12.88M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | 53.93% |
| Owned by Institutions (%) | 5.70% |
| Float | 5.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 44.22 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.14, with zero debt.
| Current Ratio | 14.14 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -118.00% and return on invested capital (ROIC) is -187.94%.
| Return on Equity (ROE) | -118.00% |
| Return on Assets (ROA) | -113.40% |
| Return on Capital (ROIC) | -187.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.08M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.80% in the last 52 weeks. The beta is 3.34, so GLSI's price volatility has been higher than the market average.
| Beta (5Y) | 3.34 |
| 52-Week Price Change | +81.80% |
| 50-Day Moving Average | 14.36 |
| 200-Day Moving Average | 12.18 |
| Relative Strength Index (RSI) | 61.82 |
| Average Volume (20 Days) | 76,632 |
Short Selling Information
The latest short interest is 229,372, so 1.78% of the outstanding shares have been sold short.
| Short Interest | 229,372 |
| Short Previous Month | 195,086 |
| Short % of Shares Out | 1.78% |
| Short % of Float | 4.04% |
| Short Ratio (days to cover) | 9.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.62M |
| Pretax Income | -9.24M |
| Net Income | -9.24M |
| EBITDA | -9.24M |
| EBIT | -9.24M |
| Earnings Per Share (EPS) | -$0.72 |
Balance Sheet
The company has $5.51 million in cash and no debt, giving a net cash position of $5.51 million or $0.43 per share.
| Cash & Cash Equivalents | 5.51M |
| Total Debt | n/a |
| Net Cash | 5.51M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 5.12M |
| Book Value Per Share | 0.40 |
| Working Capital | 5.12M |
Cash Flow
| Operating Cash Flow | -6.70M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.70M |
| FCF Per Share | -$0.52 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLSI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.09% |
| Shareholder Yield | -0.09% |
| Earnings Yield | -4.08% |
| FCF Yield | -2.96% |
Analyst Forecast
The average price target for GLSI is $36.00, which is 104.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.00 |
| Price Target Difference | 104.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |